๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

One year of oral zinc sulphate therapy in a child with Wilson's disease

โœ Scribed by MARRELLA, M; MILANINO, R; MORETTI, U; DEGANELLO, A; VELO, G

Book ID
122041617
Publisher
Elsevier Science
Year
1989
Tongue
English
Weight
79 KB
Volume
21
Category
Article
ISSN
1043-6618

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Oral zinc sulphate as primary therapeuti
Oral zinc sulphate as primary therapeutic intervention in a child with Wilson disease
โœ R. Milanino; M. Marrella; U. Moretti; G. P. Velo; A. Deganello; G. Ribezzo; L. T ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› Springer ๐ŸŒ English โš– 211 KB

An 8-year-old boy with an hepatic form of Wilson disease was treated with oral zinc sulphate as the primary and sole therapy. After 4 months, liver function had dramatically improved, and the parameters characterizing copper metabolism had also normalized.

Treatment of Wilson's disease with zinc.
Treatment of Wilson's disease with zinc. I. Oral zinc therapy regimens
โœ Gretchen M. Hill; George J. Brewer; Ananda S. Prasad; Connie R. Hydrick; Deborah ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 700 KB

The standard therapy for preventing copper accumulation in Wilson's disease, D-penicillamine, has been a life-saving drug, but it has many side effects and some patients are completely intolerant. We have been using oral zinc as another approach to the therapy for Wilson's disease, with copper balan